RUO‘ZENLog in
Stocks › Healthcare › TEVA

Teva- Pharmaceutical Industries stockTEVA

Teva- Pharmaceutical Industries Ltd · NYSE
$42.65
+0.59% on the day
Nov 11, 2026, 11:57 ET
What is happening with the stock

Teva- Pharmaceutical Industries trades at $42.65, 1.6% below its 52-week high (Nov 3, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +36.7% year to date, +69.7% over 12 months (S&P 500 over the same period: +10.7%). Next earnings report: Feb 10, 2027.

Closing price, 6 monthsdetailed chart in the terminal
29.5536.6643.7752-week high 43.34May 14, 2026Nov 11, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for TEVA — after you log in

Open the terminal
From 52-week high−1.6%
High43.34 Nov 3, 2026
vs 50-day avg+6.9%
vs 200-day avg+21.9%
Year to date+36.7%
12 months+69.7%
P/E18.0
Dividend yieldnone
EarningsFeb 10
Market cap$49.7B
Chart patternascending base
Exchange · sinceNYSE

Teva- Pharmaceutical Industries options

chain at the close on Nov 10, 2026
market expects by Nov 13±3.0%±$1.26 · from $41 to $44
put / call by volume1.26more puts traded
open interest213K156K calls · 58K puts
volume on the day6,8903,049 calls · 3,841 puts
ExpirationExpected moveVolume calls / putsOpen interestPut / Call (OI)
Nov 13 nearest±3.0%283 / 2733,9510.64
Nov 20 monthly±4.8%1,374 / 9724,7370.28
Nov 27 Friday±5.9%679 / 95,7760.13

Where open interest is largest

strikes within ±30% of price
ContractExpirationOpen interestStrike vs price
CALL $45Dec 18, 202618,397+6.2%
CALL $40Dec 18, 202617,905−5.6%
PUT $37Dec 18, 202617,626−12.7%

🔒 The full chain, IV and Greeks, combo legs and contract charts — in the terminal

Open the terminal

Earnings and price reaction

next report: Feb 10, 2027
Before the Nov 3 report the options market priced in ±7.1%. The stock moved +3.0% on the day, less than expected.
QuarterEPSEPS growthRevenueRevenue growthMarket expectedPrice on the day
Q3 2026 reported Nov 3$0.86+10.3%$4.4B−1.9%±7.1%+3.0%
Q2 2026 Jul 29$0.02−97.0%$4.1B−0.8%—+9.6%
Q1 2026 $0.53+1.9%$4.0B+2.3%——
“Market expected” is collected since Oct 21, 2026: earlier quarters have no nightly options snapshots.

🔒 Annual EPS estimates and their history, quarterly slides and the call — in the terminal

Open the terminal

Who holds the stock

as of Sep 30, 2026
funds hold it70818.8% of shares
over the quarter+499 fundswas 209
sold short2.5%of the float
days to cover5.0was 5.0
QuarterFundsChange
Sep 30, 2026708+499
Jun 30, 2026209+16
Mar 31, 2026193+9

🔒 Insiders and industry strength — in the terminal

Open the terminal

How the price behaves

from daily candles
average daily range2.9%$1.19, over 30 days
beta to the market0.32moves less than the S&P 500
volume Nov 106.22Mnear the 50-day average
over 3 months+16.7%

🔒 Buy point, RS line and signals — in the terminal

Open the terminal

Frequently asked questions about Teva- Pharmaceutical Industries

What is the Teva- Pharmaceutical Industries stock price?

At 11:57 ET on Nov 11, 2026: $42.65 (+0.59% on the day). 52-week high: $43.34 on Nov 3, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Teva- Pharmaceutical Industries report earnings?

The next quarterly report is on Feb 10, 2027. Last quarter, earnings per share changed +10% year over year, revenue −2%.

What move does the options market expect for Teva- Pharmaceutical Industries stock?

Based on option prices at the close on Nov 10, 2026, the market prices in a move of about ±3.0% (±$1.26) by Nov 13 and ±4.8% by the Nov 20 monthly expiration. This is not a forecast but what is already priced into options.

How did Teva- Pharmaceutical Industries stock react to past earnings?

After the Nov 3, 2026 report: +3.0% on the day, while the options market priced in ±7.1%, after Jul 29: +9.6%.

How many funds own Teva- Pharmaceutical Industries stock?

As of Sep 30, 2026, 708 funds, holding 18.8% of shares; over the quarter the count rose by 499. 2.5% of the float is sold short.

Does Teva- Pharmaceutical Industries pay dividends?

No, Teva- Pharmaceutical Industries does not pay dividends.

Where does Teva- Pharmaceutical Industries trade and how to buy it?

Ticker TEVA, exchange NYSE. You can buy it through a broker with access to US exchanges.

Should I buy Teva- Pharmaceutical Industries now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for TEVA are in the terminal after you log in.

Similar stocks

More on TEVA

Included in lists